A Phase I and Feasibility Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine for Pediatric Patients with Newly Diagnosed Intracranial Resectable High Grade Glioma (Arm A) and Recurrent Resectable Intracranial High Grade Glioma and Recurrent